Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison J Moskowitz

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2021
How to choose first salvage therapy in Hodgkin lymphoma: traditional chemotherapy vs novel agentsJulia Driessen, Sanne H Tonino, Alison J Moskowitz, et al.
Chinese Clinical Oncology|December 12, 2018
Cutaneous T-cell lymphoma (CTCL), rare subtypes: five case presentations and review of the literatureShamir Geller, Patricia L Myskowski, Melissa Pulitzer, et al.
International Journal of Dermatology|October 24, 2017
ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literatureShamir Geller, Theresa N Canavan, Melissa Pulitzer, et al.
Current Hematologic Malignancy Reports|October 15, 2018
Novel Immunotherapies for T Cell Lymphoma and LeukemiaPaola Ghione, Alison J Moskowitz, Nadia E K De Paola, et al.
The Journal of Dermatological Treatment|September 25, 2018
Treatment of Rosai-Dorfman disease with oral bexarotene: a case seriesShamir Geller, Klaus Busam, Paul A Hamlin, et al.
Blood Advances|April 29, 2020
Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic informationReiko Nakajima, Alison J Moskowitz, Laure Michaud, et al.
Blood Advances|January 24, 2019
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphomaNeha Mehta-Shah, Kimiteru Ito, Kurt Bantilan, et al.
The Journal of Dermatology|April 16, 2025
Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T-Cell Lymphoma: A Real-World Single-Center ExperienceViviane Liao, Leore Lavin, Michael M Ong, et al.
Journal of the American Academy of Dermatology|September 10, 2019
Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer centerShamir Geller, Emily Lebowitz, Melissa P Pulitzer, et al.
Journal of Medical Economics|October 31, 2018
Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphomaThomas E Delea, Arati Sharma, Aaron Grossman, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Hematology. American Society of Hematology. Education Program|December 10, 2021
How to choose first salvage therapy in Hodgkin lymphoma: traditional chemotherapy vs novel agentsJulia Driessen, Sanne H Tonino, Alison J Moskowitz, et al.
Chinese Clinical Oncology|December 12, 2018
Cutaneous T-cell lymphoma (CTCL), rare subtypes: five case presentations and review of the literatureShamir Geller, Patricia L Myskowski, Melissa Pulitzer, et al.
International Journal of Dermatology|October 24, 2017
ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literatureShamir Geller, Theresa N Canavan, Melissa Pulitzer, et al.
Current Hematologic Malignancy Reports|October 15, 2018
Novel Immunotherapies for T Cell Lymphoma and LeukemiaPaola Ghione, Alison J Moskowitz, Nadia E K De Paola, et al.
The Journal of Dermatological Treatment|September 25, 2018
Treatment of Rosai-Dorfman disease with oral bexarotene: a case seriesShamir Geller, Klaus Busam, Paul A Hamlin, et al.
Blood Advances|April 29, 2020
Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic informationReiko Nakajima, Alison J Moskowitz, Laure Michaud, et al.
Blood Advances|January 24, 2019
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphomaNeha Mehta-Shah, Kimiteru Ito, Kurt Bantilan, et al.
The Journal of Dermatology|April 16, 2025
Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T-Cell Lymphoma: A Real-World Single-Center ExperienceViviane Liao, Leore Lavin, Michael M Ong, et al.
Journal of the American Academy of Dermatology|September 10, 2019
Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer centerShamir Geller, Emily Lebowitz, Melissa P Pulitzer, et al.
Journal of Medical Economics|October 31, 2018
Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphomaThomas E Delea, Arati Sharma, Aaron Grossman, et al.
Pageof 10